Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Name: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma
License: Public Domain

ImmunityBio, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

relapsed b-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143544
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.